Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of S-1 Combined With Irinotecan and Oxaliplatin in Recurrent or Metastatic Gastric Carcinoma

NCT00512681 is registered in ClinicalTrials.gov with National Cancer Center, Korea as lead sponsor.

NCT NCT00512681
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00512681 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of S-1 Combined With Irinotecan and Oxaliplatin in Recurrent or Metastatic Gastric Carcinoma
Lead sponsor
National Cancer Center, Korea
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2007
Completion date
July 31, 2009
Enrollment
44 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stomach neoplasms